Nicotine treatment of obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 7, 2004, Pages 1195-1199

  Lundberg, Stefan ^a   Carlsson, Arvid ^b   Norfeldt, Per ^a   Carlsson, Maria L ^b,c  

^a Psychiatric Clinic   (Sweden)

^b Sweden   (Sweden)

^c Institute of Clinical Neurosciences   (Sweden)

Author keywords

Chewing gum; Nicotine; Obsessive compulsive disorder; YBOCS

Indexed keywords

NICOTINE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR; CHEWING GUM; DRUG RESPONSE; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; RATING SCALE; SCORING SYSTEM; STRESS;

ADULT; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL;

EID: 10944256377     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.06.014     Document Type: Article

References (15)

1. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch. Gen. Psychiatry 4 1961 561 571
2. A.T. Beck, N. Epstein, G. Brown, and R.A. Steer An inventory for measuring clinical anxiety: psychometric properties J. Consult. Clin. Psychol. 56 1988 893 897
3. M.L. Carlsson On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 2001 5 26
4. Carlsson, M.L., Carlsson A., 2000. Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder. Europe (EPC), Patent No. 1 126 846; New Zealand, Patent No. 511 226.
5. M. Davis, D. Rainnie, and M. Cassell Neurotransmission in the rat amygdala related to fear and anxiety TINS 17 1994 208 214
6. Diagnostic and Statistical Manual of Mental Disorders. Ed. 4. Rev, 1994. Washington, DC: American Psychiatric Association, Washington.
7. S.M. Dursun, M.A. Reveley, R. Bird, and F. Stirton Longlasting improvement of Tourette's syndrome with transdermal nicotine Lancet 344 1994 1577
8. H. Gäddnäs, K. Pietilä, A. Alila-Johansson, and L. Ahtee Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration Brain Res. 957 2002 76 83
9. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, R.L. Fleischmann, C.L. Hill, G.R. Heninger, and D.S. Charney The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability Arch. Gen. Psychiatry 46 1989 1006 1011
10. S. Greenland, M.H. Satterfield, and S.F. Lanes A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch Drug Safety 18 1998 297 308
11. T.R. Insel, D.L. Murphy, R.M. Cohen, I. Alterman, C. Kilts, and M. Linnoila Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline Arch. Gen. Psychiatry 40 1983 605 612
12. S.H. Jones, G. Thornicroft, M. Coffey, and G. Dunn A brief mental health outcome scale. Reliability and validity of Global Assessment of Functioning (GAF) Br. J. Psychiatry 166 1995 654 659
13. J.V. Lucey, G. Butcher, A.W. Clare, and T.G. Dinan Elevated growth hormone responses to pyridostigmine in obsessive-compulsive disorder: evidence of cholinergic supersensitivity Am. J. Psychiatry 150 1993 961 962
14. M.-M. Mesulam, L. Volicer, J.K. Marquis, E.J. Mufson, and R.C. Green Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications Ann. Neurol. 19 1986 144 151
15. D.H. Zald, J.T. Lee, L.K.W. Fluege, and J.V. Pardo Aversive gustatory stimulation activates limbic circuits in humans Brain 121 1998 1143 1154